Tumour necrosis factor (TNF) induces antiviral activity in HEp-2 cells. Virus yield reduction assays with vesicular stomatitis virus as challenging virus demonstrated that the antiviral state was more pronounced in confluent cultures under low serum conditions. A significant enhancement of the antiviral state was obtained by combining TNF with low concentrations of either interferon (IFN)-fl 1 or IFN-~. The reduction in virus yield was significantly higher than that expected from summation of the independent antiviral activities of either substance alone, i.e. TNF and IFN acted synergistically as antiviral agents. Synergism of TNF with IFN-fl or IFN-~ appeared to be mediated by different pathways, since different requirements for pretreatment and different effects on oligo°2',5'-adenylate synthetase (2-5AS) induction were observed. Induction of 2-5AS by TNF could be shown to be an indirect event that was sensitive to an antiserum against natural IFN-/~ 1.
Tumour necrosis factor (TNF) was first described by Carswell et al. (1975) as a serum factor of mice treated sequentially with BCG and lipopolysaccharide. It was shown to have antitumoural activity in vivo as well as cytotoxic activity on transformed cells in vitro. Since the cloning of human and mouse TNF genes (Pennica et al., 1984; Shirai et al., 1985; Wang et al., 1985; Fransen et al., 1985; Marmenout et al., 1985) pure recombinant TNF (rTNF) has become available and evidence has accumulated that TNF has an additional variety of biological effects. TNF was shown to have a growth factor-like effect on human diploid fibroblasts (Sugarman et al., 1985; Vilcek et al., 1986) , to stimulate production of interleukin 1 in endothelial cells or monocytes (Dinarello et al., 1986; Nawroth et al., 1986) and to modulate functions of the immune system, e.g. to enhance the activities of immunocompetent cells such as neutrophils (Shalaby et al., 1985; Klebanoff et al., 1986) or eosinophils (Silberstein & David, 1986) . In a recent review, Old (1985) suggested that TNF may have evolved as a factor with a role in defence against infectious diseases. In accordance with this theory we and others reported that TNF induced an antiviral state in several cell lines (HEp-2, WI-38, HEL) leading to a reduction of virus yields in cells infected with vesicular stomatitis virus (VSV) (Mestan et al., 1986; Kohase et al., 1986; Wong & Goeddel, 1986) . In this report we discuss the effects of culture conditions and combination with interferons on the antiviral activity of TNF.
Pretreatment of HEp-2 cells with human rTNF leads to a dose-dependent inhibition of VSV replication, which is observed in cell protection assays as well as in virus yield assays. Dose dependence is affected both by cell confluence and serum concentration in growth medium and is more pronounced in aged, fully confluent monolayers and at low serum conditions. The latter point is demonstrated in Fig. 1 , where confluent HEp-2 cells were pretreated with increasing amounts of rTNF in the presence of 1% or 10 % calf serum (CS) and virus yield was assayed. Low serum conditions resulted in a 10-to 60-fold increase in virus inhibition. These results are in Subsequently all monolayers were washed and infected with VSV in MEM at an m.o.i, of 0.2. After 1 h cells were washed twice and 200 I11 of fresh MEM, 10~ CS was added followed by incubation at 37 °C, 5% CO2 for 24 h. Virus yields were determined in a plaque assay on confluent RITA cell (monkey kidney cells, RC-37 RITA; Italdiagnostics, Rome, Italy) monolayers in six-well plates. After freezethawing (-70 °C) virus-containing supernatants were diluted with basal medium Eagle (BME) in 10-fold dilution steps. RITA cell monolayers were infected with 200 td virus suspension per well and incubated for 1 h. Subsequently overlay medium (BME, 1 ~ carboxymethyl cellulose, 5 ~ foetal CS) was added. After incubation for 24 h cells were fixed with 3 ~ formaldehyde, stained with gentian violet and plaques were counted to determine the virus titre (p.f.u./ml). Reduction of virus yields is expressed in log10 of difference in virus titres compared to virus controls (1.86 x 10 s p.f.u./ml for a; 2.04 x 10 s p.f.u./ml for b). The TNF was recombinant material with a specific activity of 2.9 x 107 U/mg measured in a L-929 cytotoxicity assay. Recombinant IFN-fl and IFN-? (specific activities 3 x 10 a and 4 x 107 IU/mg protein, respectively) were a gift of Bioferon GmbH, Laupheim, F.R.G. agreement with observations of Kohase et al. (1986) obtained in TNF-treated cultures of human foreskin fibroblasts.
The cytotoxic activity of TNF is greatly enhanced by combination with IFN-~ and similar findings have been reported for its antiviral activity on A549 cells (Wong & Goeddel, 1986) . We have analysed the effect of combinations of TNF with IFN-~ or IFN-fl 1 on VSV replication in HEp-2 cells. Fig. 1 compares the antiviral activities of various concentrations of TNF alone with those of TNF in combination with 10 international units (IU)/ml of IFN-~ or IFN-fl 1. In 10~ serum in the absence of IFNs the maximum virus yield reduction is still not obtained with doses of TNF as high as 100 ng/ml (Fig. 1 a) . Treatment with concentrations of IFN-fl or IFN-? which by themselves lead to a 1 to 1.8 log10 reduction in virus yield greatly enhance the antiviral effect of TNF, resulting in maximal virus inhibition with TNF concentrations of less than 10 ng/ml. Both IFNs lead to a comparable enhancement of the antiviral activity of TNF. Especially at lower TNF doses the enhancement is 10-to 100-fold above the activity calculated by summation of the individual activities, thus fulfilling criteria for a synergistic effect. Enhanced antiviral activity was not due to an increased cytotoxic activity of the combined treatment. This was demonstrated by cell protection assays comparing intact cell monolayers after virus infection to untreated, virus-infected controls (data not shown). These results were obtained with cells grown in 10~ serum. Treatment with TNF at a low serum concentration (1 ~) potentiated its activity to such an extent that enhancement by IFN was less significant (Fig. l b) . The following experiments were thus performed at high serum concentrations (10~) allowing optimal synergism. 
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We next investigated whether synergism requires pretreatment with both agents simultaneously or whether the induction of the antiviral state could be dissected by sequential treatment with each substance alone. To this end, cells were either treated with both substances together or sequentially treated with IFN and TNF in various orders (Fig. 2 , see legend for details). Fig.  2 (a) gives the results for an experiment with TNF and IFN-~. The upper three bars indicate the reductions in virus yield in cultures which were either treated with each substance alone or together for 13 h before infection. More than 10-fold enhancement in virus inhibition was obtained by simultaneous treatment. The middle three bars summarize an experiment where treatment with IFN-~ preceded treatment with TNF (plus two controls with each substance alone to compare virus inhibitions). Sequential treatment with both agents potentiates reduction in virus yield although at any given time of pretreatment cells were only subjected to treatment with each agent alone. The lower three bars give the result of a similar experiment with TNF treatment preceding IFN-7. Under these experimental conditions, however, no synergistic effect is observed since virus inhibition in cultures treated with both agents is no more than the sum of the inhibitions observed after pretreatment with either substance alone.
In Fig. 2 (b) this experiment is repeated with TNF and IFN-fll instead of IFN-~. Simultaneous treatment with both substances leads to the expected synergism (upper bars) as does IFN-fll treatment preceding that with TNF (middle bars). Interestingly, however, conditions where TNF precedes IFN-fl 1 also lead to virus inhibition exceeding that expected for treatment with either substance alone. Thus, IFN-~ differs from IFN-fl 1 in its capability to synergize with TNF as an antiviral factor in that it is more restricted in its requirements for induction of the antiviral state.
Since IFN-), reportedly enhances the expression of TNF-specific binding sites on several cell lines including HeLa or L929 cells we assayed the binding activity of HEp-2 cells. In Fig. 3 a Scatchard plot analysis of 125i_labelled TNF binding to control and IFN-~-pretreated cells is shown. Even at high concentrations (500 U/ml) IFN-~ causes only a 30 to 50 ~ increase in TNF-binding sites starting from a basal level of 1500 to 2500 per cell in different experiments. Binding affinities of TNF to IFN-~-treated cells were either unaltered or even slightly decreased when compared with control cells (Fig. 3) . IFN-fl 1 pretreatment of HEp-2 cells was without effect on TNF binding (data not shown). Hence, we conclude that modulation of TNF binding by IFNs is not a sufficient prerequisite for synergistic action.
It has been shown that TNF treatment leads to an increase in oligo-2',5'-adenylate synthetase (2-5AS) levels (Mestan et al., 1986; Wong & Goeddel, 1986) . Since this enzyme may be involved (Fraker & Speck, 1978) . The product was 99 ~ acid-precipitable after gel filtration through a PD10 column (Pharmacia) and had a specific radioactivity of approx. 600 Ci/mmol protein retaining full cytotoxic activity. HEp-2 cells were seeded into C-6 plates (Costar) 2 days before the binding assay. IFN-y was added 16 h before the experiment at 500 U/ml. Cells were preincubated at 37 °C for 15 min with complete medium containing 0.1 ~ sodium azide in order to prevent internalization of bound ligand. The cells (3.5 x 106) were incubated with 125I-labelled TNF for 90 rain at 37 °C in the same medium. Control wells with 1000 times the concentration of unlabelled TNF were incubated in parallel to enable determination of nonspecific binding. The adherent cells were washed five times with cold phoSphate-buffered saline, lysed with 2~ Triton X-100 and counted. All data are the mean of duplicate determinations showing less than 5~ deviation from each other.
in the antiviral state, we decided to assay its activity in TNF-or TNF/IFN-treated HEp-2 cells (Fig. 4 ) in addition to virus yield assays as a possible marker for synergism. Pretreatment with either TNF or IFN increased 2-5AS activity. Combined treatment with both TNF and IFN-fl 1 enhanced the induction more than twofold. In contrast, treatment with TNF and IFN-~ resulted in enzyme activities not higher than those observed with IFN-~ or TNF alone. Oligo-2',5'-adenylate synthetase induction by IFN-fll is a primary response, i.e. gene activation and mRNA accumulation occur in the presence of inhibitors of protein synthesis whereas induction by IFN-~ has been reported to be sensitive to such inhibitors (Faltynek et al., 1985) . We have found that in HEp-2 cells the level of synthetase-specific mRNA is much reduced when TNF treatment occurs in the presence of cycloheximide (data not shown) pointing to an indirect induction pathway. Since so far only IFNs have been described as specific inducers of this activity, it was of interest to determine whether its induction was due to an IFN-like intermediate. We and others have reported previously that the induction of the antiviral state can be blocked to a variable extent by the addition of an antiserum to natural IFN-fl 1 (Mestan et al., 1986; Van Damme et al., 1987) . In Fig. 5(a) an experiment is shown where cultures were treated with TNF in the presence or absence of an antiserum to IFN-# 1 and subsequently assayed for 2-5AS activity. Included is a control experiment in which cells were treated with the dsRNA poly(I)-poly(C), a potent inducer of IFN-/~ in fibroblast cell lines. Induction of 2-5AS is greatly reduced in those cultures which were treated with the neutralizing antiserum. The specificity of this effect is underlined by the results of a Northern blot analysis for 2-5AS- The assay for measuring 2-5AS activity was performed as described elsewhere (Knight et al., 1980; Silverman et al., 1982) . Briefly, after harvesting and washing cells were lysed in NP40-containing lysis; buffer and centrifuged at 12000 g for 10 min at 4 °C. The protein content of the supernatant was determined using a Bio-Rad protein assay kit with bovine serum albumin as the standard. Protein (200 ixg) from each supernatant was added to 20 ~tl poly(I).poly(C)-agarose (Pharrnacia) followed by incubation for 1 h at room temperature and three washes to remove unbound material with DBG buffer (50 mt, l-KC1, 1.5 mra-magnesium acetate, 20~ v/v glycerol, 7 m~l-2-mercaptoethanol, 10 mM-HEPES pH 7.5). DBG (15 ~tl) containing 15 mM-MgC12 and 8 mM-ATP as substrate for 2-5AS was added and incubated for 3 h at 37 °C. Subsequently the poly(I)-poly(C)-agarose was removed by centrifugation and serial dilutions of the supernatant were mixed with 10 ~tl L-929 cell extract containing 200 Ixg protein and with 5 ~tl ppp(A2'p)3A3"[3~P]pCp (1000 c.p.m./txl) radiolabelled according to Knight et at. (1980) . After incubation for 1 h at 4 °C the reaction mixture was transferred to small pieces of nitrocellulose sheet and washed twice in distilled water to remove unbound material. The radioactivity bound to the nitrocellulose sheets was measured in a liquid scintillation counter. The concentration of the synthesized 2'-5'An was evaluated using a standard competition curve with serial dilutions of unlabelled 2'-5"A4 used to provide a standard. Activity of 2-5AS is expressed in units such that 1 unit is defined as pmol 2'-5'An produced/mg protein/h. specific transcripts (Fig. 5 b) . Whereas there is a large increase in mRNA in TNF-treated cells, this increase is largely cancelled when an antiserum to IFN-fl is included. Together these data prove that 2-5AS induction by TNF is indirect and mediated by a TNF-induced, IFN-fl-like activity. However, induction of IFN-//1 by TNF has not been directly demonstrated, either by Northern blot analysis or by detection of IFN activity in supernatants from TNF-treated cultures. This may either reflect the induction of a mediator different from IFN-fl l, which is not detected by the latter methods, or the production of very small amounts of IFN-fl 1. Since our experiments demonstrate that small amounts of exogenous IFN-fl 1 are sufficient to potentiate the activity of TNF by more than an order of magnitude, it seems possible that endogenous TNF-induced IFN-fl 1 below the level of detection could play a decisive role in the TNFmediated antiviral state, e.g. as inducer of 2-5AS. This raises the question of whether the sole role of TNF in the establishment of the antiviral state is that of an inducer of an IFN-fl activity with no antiviral activity on its own. Such a model, however, would not explain the synergism in antiviral activity observed after treatment of HEp-2 cells with TNF and exogenous IFN-fl I but would rather predict an additive effect. Our observations therefore favour a model where TNF and some induced IFN-fl-like activity combine to cause antiviral activity.
It has been demonstrated that TNF induced IFN-fl2 (interleukin 6, 26K protein) activity in various cells (Kohase et al., 1986; DeFilippi et al., 1987) . We have also measured increased levels (Chirgwin et al., 1979) and purified through a CsC1 cushion. It was separated on a denaturing formaldehyde gel (20 ~tg per lane) and blotted onto nylon membrane and hybridized essentially as described by Maniatis et al. (1982) . Hybridization was for 18 h at 42 °C in 50 ~ formamide, 5 x SSPE, 5 x Denhardt's solution, 1 ~ SDS and 200 ~tg/ml of yeast RNA containing 1-5 x 106 c.p,m./ml of a cDNA of the human 2-5AS gene which was labelled to 1 × 109to2 × 109c.p.m./~tgbytheincorporationof[3zp]dCTPinarandomprimingreaction (Feinberg & Vogelstein, 1983) . Stringent washing was for 60 min at 68 °C in 2 × SSC, 0.1 ~ SDS. Radioactively labelled bands were visualized by autoradiography on Kodak X-AR film.
of IFN-/?2 m R N A in TNF-treated HEp-2 cells as well as a B cell-stimulating activity in the supernatants of such cultures (data not shown). Although its role in this system remains to be established using either purified IFN-fl2 or monospecific antiserum our failure to detect antiviral activity in supernatants of TNF-treated cultures argues against a role of IFN-/~2 as an independent mediator of the antiviral activity of T N F . Both IFN-//1 and IFN-~, potentiate the antiviral activity of T N F . However, our induction experiments point to different mechanisms underlying this synergism. IFN-y may increase the responsiveness of cells to T N F and therefore require concomitant treatment for extended periods or IFN-7 treatment preceding that with TNF. Our binding data suggest that modulation of T N F -b i n d i n g sites by IFN-y is of only minor importance for this effect. For IFN-/~ 1 a different mode of action has to be assumed, since its interaction with T N F is unaffected by the sequence of treatment. Together with previous reports on synergisms of IFN-~ with either IFN-/? or IFN-7 (Czarniecki et al., 1984; Oleszak & Stewart, 1985) our results suggest a network of multiple interactions through which these cytokines exert their activities leading to the induction of an antiviral state.
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